BSE · 526345
Panjon Ltd.
Revenue & net profit by period
Bars = revenue (₹ Cr) · line = net profit (₹ Cr). Straight from disclosed results.
Latest period: revenue ₹13 Cr with net profit ₹0 Cr — a 2.84% net margin, versus -17.58% the period before.
Shareholding
As of 2026-06-30
- Promoter56.69%
- Public43.31%
10,380 shareholders on record
Promoter holding trend
Each disclosed period, oldest to newest
52-week position
Where the current price sits in its yearly band
The band spans 1.86× from low to high.
Risk flags
Derived from disclosed data
No flags raised by the data.
Peer comparison
Pharmaceuticals - Indian - Formulations · ranked #35 of 50 by market cap · medians across 42 industry peers
| Company | Mkt cap | P/E | P/B | ROE | Margin |
|---|---|---|---|---|---|
| Torrent Pharmaceuticals Limited | ₹1,86,167 Cr | 84.94 | 22.14 | 25.49% | 15.55% |
| Ajanta Pharma Limited | ₹43,140 Cr | 161.73 | 9.56 | 23.33% | 19.37% |
| Gland Pharma Limited | ₹42,307 Cr | 115.22 | 4.08 | 9.92% | 15.98% |
| Rubicon Research Limited | ₹24,973 Cr | 101.21 | 19.38 | 19.14% | 14.07% |
| Caplin Point Laboratories Ltd. | ₹19,979 Cr | 117.44 | 5.57 | 17.88% | 29.32% |
| Eris Lifesciences Limited | ₹19,329 Cr | 67.71 | 4.95 | 15.87% | 19.89% |
| Shilpa Medicare Ltd. | ₹11,870 Cr | 50.87 | 4.58 | 9.39% | 15.81% |
| Marksans Pharma Limited | ₹11,714 Cr | 28.04 | 3.87 | 13.82% | 14.16% |
| Senores Pharmaceuticals Limited | ₹6,051 Cr | 47.89 | 6.48 | 12.36% | 18.59% |
| Bliss GVS Pharma Ltd. | ₹4,879 Cr | 142.86 | 4.08 | 8.95% | 11.15% |
| Panjon Ltd.(this company) | ₹31 Cr | 43.45 | 1.84 | 4.25% | 1.51% |
AI analysis
AI-generated · google/gemini-2.5-flashPanjon Ltd. is listed on the Indian markets with a market capitalization of Rs 31 Cr. The company reported a revenue of Rs 12.69 Cr. Its EPS stands at 0.42 and P/E ratio is 42.55.
Positives
- +The company's debt-to-equity ratio is low at 0.09.
- +Promoter holding is 56.6856%, indicating significant insider ownership.
- +No promoter shares are pledged, with a promoter pledge percentage of 0.0%.
Negatives
- −The dividend yield is 0%, indicating no dividend payouts.
- −Quarterly revenue has fluctuated from Rs 14.95 Cr in September 2025 to a low of Rs 6.42 Cr in June 2025, suggesting inconsistency.
- −The Return on Capital Employed (ROCE) is low at 4.7304%.
Financial performance
Panjon Ltd. achieved a revenue of Rs 12.69 Cr. The company's most recent quarterly revenue was Rs 12.12 Cr for March 2026, with a net profit of Rs 0.19 Cr. Over the past year, quarterly revenues have fluctuated, peaking at Rs 14.95 Cr in September 2025 and seeing a low of Rs 6.42 Cr in June 2025.
Profitability & returns
The company recorded an Earnings Per Share (EPS) of 0.42. The Return on Capital Employed (ROCE) is 4.7304% and Return on Equity (ROE) is 425.4%. The profit margin for the period stands at 151.2%.
Balance sheet
Panjon Ltd. has a low debt-to-equity ratio of 0.09. The book value per share is Rs 9.92.
Ownership & pledges
Public shareholding is 43.3144%. There are no shares pledged by the promoters, as indicated by a pledge percentage of 0.0%.
Data as of — price: 2026-07-30 · financials: Mar 16 · shareholding: Jun 26. Figures are restated only when the company files again, so a period shown here is the most recent one on record — not necessarily the current quarter.
How this is produced: every figure above is computed from exchange filings and financial data mirrored by IPO Plus — no figure is generated or estimated. This is a factual summary for information and education only. It is not investment advice, not a recommendation to buy, sell or hold any security, and contains no price targets. Verify against the company's filings and the exchanges before any decision.